Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1915 2
1923 1
1924 1
1929 1
1930 1
1931 1
1935 2
1938 2
1952 1
1965 1
1972 1
1973 1
1974 2
1975 1
1976 2
1977 8
1978 3
1979 3
1980 3
1981 23
1982 6
1983 10
1984 4
1985 3
1986 8
1987 10
1988 8
1989 7
1990 13
1991 12
1992 22
1993 16
1994 16
1995 18
1996 21
1997 11
1998 16
1999 22
2000 18
2001 1
2002 8
2003 12
2004 7
2005 12
2006 10
2007 17
2008 17
2009 25
2010 25
2011 26
2012 25
2013 28
2014 30
2015 31
2016 38
2017 40
2018 40
2019 33
2020 43
2021 40
2022 26
2023 34
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

783 results

Results by year

Filters applied: . Clear all
Page 1
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, Lane NE, Ma NS, Magrey M, McAlindon T, Robinson AB, Saha S, Womack C, Abdulhadi B, Charles JF, Cheah JTL, Chou S, Goyal I, Haseltine K, Jackson L, Mirza R, Moledina I, Punni E, Rinden T, Turgunbaev M, Wysham K, Turner AS, Uhl S. Humphrey MB, et al. Among authors: gore s. Arthritis Rheumatol. 2023 Dec;75(12):2088-2102. doi: 10.1002/art.42646. Epub 2023 Oct 16. Arthritis Rheumatol. 2023. PMID: 37845798 Review.
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Among authors: gore sd. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Bewersdorf JP, Xie Z, Bejar R, Borate U, Boultwood J, Brunner AM, Buckstein R, Carraway HE, Churpek JE, Daver NG, Porta MGD, DeZern AE, Fenaux P, Figueroa ME, Gore SD, Griffiths EA, Halene S, Hasserjian RP, Hourigan CS, Kim TK, Komrokji R, Kuchroo VK, List AF, Loghavi S, Majeti R, Odenike O, Patnaik MM, Platzbecker U, Roboz GJ, Sallman DA, Santini V, Sanz G, Sekeres MA, Stahl M, Starczynowski DT, Steensma DP, Taylor J, Abdel-Wahab O, Xu ML, Savona MR, Wei AH, Zeidan AM. Bewersdorf JP, et al. Among authors: gore sd. Blood Rev. 2023 Jul;60:101072. doi: 10.1016/j.blre.2023.101072. Epub 2023 Mar 11. Blood Rev. 2023. PMID: 36934059 Review.
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Stahl M, Bewersdorf JP, Xie Z, Porta MGD, Komrokji R, Xu ML, Abdel-Wahab O, Taylor J, Steensma DP, Starczynowski DT, Sekeres MA, Sanz G, Sallman DA, Roboz GJ, Platzbecker U, Patnaik MM, Padron E, Odenike O, Nimer SD, Nazha A, Majeti R, Loghavi S, Little RF, List AF, Kim TK, Hourigan CS, Hasserjian RP, Halene S, Griffiths EA, Gore SD, Greenberg P, Figueroa ME, Fenaux P, Efficace F, DeZern AE, Daver NG, Churpek JE, Carraway HE, Buckstein R, Brunner AM, Boultwood J, Borate U, Bejar R, Bennett JM, Wei AH, Santini V, Savona MR, Zeidan AM. Stahl M, et al. Among authors: gore sd. Blood Rev. 2023 Nov;62:101128. doi: 10.1016/j.blre.2023.101128. Epub 2023 Aug 19. Blood Rev. 2023. PMID: 37704469 Review.
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.
Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H. Cheson BD, et al. Among authors: gore sd. Blood. 2006 Jul 15;108(2):419-25. doi: 10.1182/blood-2005-10-4149. Epub 2006 Apr 11. Blood. 2006. PMID: 16609072 Free article.
Decitabine.
Gore SD, Jones C, Kirkpatrick P. Gore SD, et al. Nat Rev Drug Discov. 2006 Nov;5(11):891-2. doi: 10.1038/nrd2180. Nat Rev Drug Discov. 2006. PMID: 17117522 No abstract available.
Extraocular Orbital and Peri-Orbital Masses.
Biswas A, Wong OY, Aygun B, Gore S, Mankad K. Biswas A, et al. Among authors: gore s. Neuroimaging Clin N Am. 2023 Nov;33(4):643-659. doi: 10.1016/j.nic.2023.05.012. Epub 2023 Jul 1. Neuroimaging Clin N Am. 2023. PMID: 37741663 Review.
Neuroimaging of Ocular Abnormalities in Children.
Aygun B, Biswas A, Taranath A, Yildiz H, Gore S, Mankad K. Aygun B, et al. Among authors: gore s. Neuroimaging Clin N Am. 2023 Nov;33(4):623-641. doi: 10.1016/j.nic.2023.05.011. Epub 2023 Jul 7. Neuroimaging Clin N Am. 2023. PMID: 37741662 Review.
Demethylation demystification.
Suarez L, Gore SD. Suarez L, et al. Among authors: gore sd. Blood. 2013 Feb 28;121(9):1488-9. doi: 10.1182/blood-2013-02-483735. Blood. 2013. PMID: 23449614 Free PMC article.
783 results